You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies
- Disease
- rheumatoid arthritis
- Drug Name
- Fostamatinib Disodium
- Generic Name
- Fostamatinib
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Aug 29, 2008
- Study Name
- C-935788-012
- Study Id
- D4300C00021
- ClinicalTrials.gov ID
- NCT00805467
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
